Seeing Is Believing
Currently out of the existing stock ratings of Gary Nachman, 166 are a BUY (67.21%), 79 are a HOLD (31.98%), 2 are a SELL (0.81%).
Analyst Gary Nachman, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 41.36% that have a potential upside of 30.25% achieved within 170 days.
Gary Nachman’s has documented 507 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABBV, AbbVie at 03-Feb-2025.
Analyst best performing recommendations are on LCI (LANNETT COMPANY).
The best stock recommendation documented was for MNK (MALLINCKRODT PLC) at 9/5/2019. The price target of $3 was fulfilled within 5 days with a profit of $1.41 (88.68%) receiving and performance score of 177.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1 months 20 days ago
(10-Apr-2025)
6/6 (100%)
$3.41 (15.79%)
263
Hold
$32
$7.53 (30.77%)
$36
2 months 9 days ago
(21-Mar-2025)
10/15 (66.67%)
$3.71 (13.11%)
337
Buy
$55
$30.53 (124.77%)
$62
9 months 18 days ago
(12-Aug-2024)
2/5 (40%)
$11.75 (27.17%)
105
Buy
$117
$92.53 (378.14%)
$63
1 years 3 months 2 days ago
(28-Feb-2024)
1/2 (50%)
$62.26 (113.74%)
48
Hold
$44
$19.53 (79.81%)
$40
2 years 13 days ago
(17-May-2023)
5/5 (100%)
$1.03 (2.40%)
86
Which stock is Gary Nachman is most bullish on?
What Year was the first public recommendation made by Gary Nachman?